SCG Therapy Opens Cell Therapy Manufacturing Facility in Singapore

The new facility is set to utilize and extend SCG’s capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology.